Author(s): Fisher ND, Hollenberg NK
Abstract Share this page
Abstract Blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers has become a crucial element in cardiovascular and renal medicine. This review evaluates the potential of renin inhibition as an adjunct to therapies that depend on renin system interruption.
This article was published in J Am Soc Nephrol
and referenced in Journal of Diabetes & Metabolism